Merit Medical Q2 2020 Earnings Report
Key Takeaways
Merit Medical reported a decrease in revenue for Q2 2020, with a worldwide revenue of $218.4 million, a (14.5)% decrease compared to Q2 2019. The company reported a GAAP loss per share of $(0.34) and a non-GAAP EPS of $0.31. Despite the revenue decline, the company generated $32 million in free cash flow and continued progress on strategic goals.
Worldwide revenue decreased by (14.5)% to $218.4 million compared to Q2 2019.
Core revenue on a constant currency basis decreased by (13.6)% compared to Q2 2019.
GAAP loss per share was $(0.34), compared to GAAP EPS of $0.12 in Q2 2019.
Non-GAAP EPS was $0.31, compared to $0.42 in Q2 2019.
Merit Medical
Merit Medical
Merit Medical Revenue by Segment
Forward Guidance
Due to the general uncertainty and rapidly changing global environment related to the COVID-19 pandemic and corresponding economic downturn, Merit’s management has concluded that it cannot issue financial guidance for the remainder of 2020.
Revenue & Expenses
Visualization of income flow from segment revenue to net income